1.A Case of Posterior Pharyngeal Wall Perforation After Blunt Neck Trauma
Jae-Yeop SIM ; Joon Don LEE ; HeeJun YI
Journal of the Korean Society of Laryngology Phoniatrics and Logopedics 2024;35(1):35-39
Perforation of the pharynx due to external blunt trauma is an uncommon type of pharyngeal injury. It can lead to serious complications such as deep neck infection, sepsis, mediastinitis, and even mortality if not promptly recognized and treated. Therefore, early diagnosis and treatment are crucial to prevent severe consequences and long-term complications. If the size of the injury is less than 2 cm and there is no invasion of the esophagus or mediastinum, conservative, nonsurgical treatment may be appropriate. In this case report, we present a case of retropharyngeal wall perforation following external blunt neck trauma with literature review.
2.Outcomes of Salvage Therapy for Oropharyngeal Cancer Recurrence Following Upfront Radiation Therapy and Prognostic Factors
Nayeon CHOI ; Hack Jung KIM ; Heejun YI ; Heejung KIM ; Tae Hwan KIM ; Han-Sin JEONG ; Young-Ik SON ; Chung-Hwan BAEK ; Dongryul OH ; Yong Chan AHN ; Man Ki CHUNG
Cancer Research and Treatment 2023;55(4):1123-1133
Purpose:
This study aimed to investigate the oncologic outcomes and prognostic factors of salvage treatments in patients with recurrent oropharyngeal squamous cell carcinoma (OPSCC) after radiotherapy (RT)-based treatment.
Materials and Methods:
A cancer registry was used to retrieve the records of 337 patients treated with definitive RT or concurrent chemoradiotherapy (CRT) from 2008 to 2018 at a single institution. The poor-responder group (PRG) was defined as patients with residual or recurrent disease after primary treatment, and the oncologic outcomes for each salvage treatment method were analyzed. In addition, prognostic indicators of recurrence-free survival (RFS) and overall survival (OS) were identified in patients who underwent salvage treatment.
Results:
After initial (C)RT, the PRG comprised 71 of the 337 patients (21.1%): 18 patients had residual disease, and 53 had recurrence after primary treatment (mean time to recurrence 19.5 months). Of these, 63 patients received salvage treatment (surgery 57.2%, re-(C)RT 23.8%, and chemotherapy 19.0%), and the salvage success rate was 47.6% at the last follow-up. The overall 2-year OS for salvage treatments was 56.4% (60.8% for the salvage surgery group and 46.2% for the salvage re-(C)RT). Salvage surgery patients with negative resection margins had better oncologic outcomes than those with close/positive resection margins. Using multivariate analyses, locoregional recurrence and residual disease after primary surgery were associated with poor outcome after salvage treatment. In Kaplan-Meier analyses, p16 status was significantly associated with OS in the initial treatment setting but not in the salvage setting.
Conclusion
In recurrent OPSCC after RT-based treatment, successful salvage was achieved in 56.4% patients who had undergone salvage surgery and radiation treatment. Salvage treatment methods should be selected carefully, given recurrence site as a prognostic factor for RFS.